Related Experiment Video
Updated: Feb 2, 2026
05:10
Drug Repurposing Hypothesis Generation Using the "RE:fine Drugs" System
Published on: December 11, 2016
10.2K
Summary
The pharmaceutical industry exploited a lack of government action on drug pricing. This inaction allowed companies to maintain high prices, impacting consumers and healthcare costs.
Area of Science:
- Health Policy
- Pharmaceutical Economics
Background:
- High prescription drug prices represent a significant burden on patients and the healthcare system.
- Previous administrations have attempted to address drug pricing without substantial success.
Purpose of the Study:
- To analyze the pharmaceutical industry's response to a perceived policy vacuum regarding drug pricing under the Trump administration.
- To examine the strategies employed by the pharmaceutical industry in the absence of federal drug price regulation.
Main Methods:
- Qualitative analysis of pharmaceutical industry lobbying efforts and public statements.
- Review of drug pricing trends and legislative actions during the specified political period.
Main Results:
- The pharmaceutical industry actively lobbied against price controls.
- Drug prices continued to rise, with limited legislative intervention.
- Industry profits remained robust despite public and political pressure.
Conclusions:
- The absence of decisive political action created an environment conducive to sustained high drug prices.
- The pharmaceutical industry effectively leveraged the policy vacuum to its financial advantage.
More Related Videos
07:39SA-β-Galactosidase-Based Screening Assay for the Identification of Senotherapeutic Drugs
Published on: June 28, 2019
25.2K
07:02A Computerized Test Battery to Study Pharmacodynamic Effects on the Central Nervous System of Cholinergic Drugs in Early Phase Drug Development
Published on: February 11, 2019
10.3K
Related Concept Videos
01:25Pharmacokinetics: Drug–Drug Interactions
446
Drug interactions occur when the pharmacological effect of one drug is altered by another substance, either enhancing or diminishing its activity. The drug whose activity is altered is known as the object drug, and the substance causing the alteration is called the agent drug or the precipitant. The net effects of these interactions are mostly undesirable, leading to decreased effectiveness or increased adverse effects. In rare cases, interactions can be beneficial, such as the enhanced...
446
01:09Bioequivalence of Drugs: Drugs with Multiple Indications
159
The concept of therapeutic equivalence (TE) in drugs with multiple indications is complex. A generic drug may be therapeutically equivalent to a brand-name product for one specific indication, but this doesn't necessarily mean it's equivalent for all other indications. Evidence of TE in one patient group and bioequivalence shown in healthy volunteers can support—but not confirm—TE for other indications. However, definitive proof requires individual clinical studies for each...
159
01:26FDA Approved Drugs: Changes to Approved Drugs
269
Post-approval, manufacturers may modify an approved new or generic drug product. Such modifications can encompass alterations in the Active Pharmaceutical Ingredient (API), manufacturing process, formulation, batch size, manufacturing site, and container closure system (FDA Guidance for Industry, April 2004). Often, a drug product may undergo multiple changes.These modifications require careful evaluation to determine their potential impact on the drug product's identity, strength, quality,...
269
01:27Factors Influencing Drug Absorption: Drug Dissolution
1.2K
The pharmacokinetic journey of drugs from solid oral dosage forms into systemic circulation is multifaceted. It begins with disintegration, a prerequisite ensuring a solid dosage form's subdivision into minute particles. Dissolution occurs next as these granulated entities solubilize in gastrointestinal fluids. This solubilization is crucial for the succeeding stage, permeation, which describes the traversal of the drug across the intestinal membrane and its subsequent entry into the blood...
1.2K
01:18Factors Affecting Protein-Drug Binding: Drug-Related Factors
485
Drug binding to proteins is a complex phenomenon influenced by various drug-related factors, each playing a significant role in the interaction between drugs and proteins within the body.
One crucial factor in drug-protein binding is the drug's lipophilicity or its affinity for fat. More lipophilic drugs tend to have higher binding extents. For example, highly lipophilic drugs like cloxacillin exhibit substantial protein binding, with as much as 95% of the drug binding to proteins. In...
One crucial factor in drug-protein binding is the drug's lipophilicity or its affinity for fat. More lipophilic drugs tend to have higher binding extents. For example, highly lipophilic drugs like cloxacillin exhibit substantial protein binding, with as much as 95% of the drug binding to proteins. In...
485
01:26Pharmacokinetics: Drug–Food and Drug–Viral Interactions
252
A drug interaction occurs when the concurrent use of another drug, food, or an external substance alters the pharmacological activity of a drug. This interaction can modify the action of the original drug, affecting its effectiveness and safety.Drug–food interactions are significant as they impact drug absorption, metabolism, and excretion. For example, grapefruit juice is a well-known disruptor of drug metabolism. It inhibits the cytochrome P450 3A4 enzyme, crucial for the metabolism of...
252